When was Defibrio founded?

Defibrio was founded in 2020 and raised its 1st funding round 2 years after it was founded.

Where is Defibrio located?

Defibrio is headquartered in Bergen, Norway.

How many employees does Defibrio have?

As of Dec 31, 2022, the latest employee count at Defibrio is 1.

Is Defibrio a funded company?

Defibrio is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Mar 20, 2022.

When was the latest funding round of Defibrio?

Defibrio's latest funding was a $***** Seed round on Mar 20, 2022, with participation from 1 investor.

What is the annual revenue of Defibrio?

Annual revenue of Defibrio is less than $1M as on Dec 31, 2022

Where does Defibrio rank among its competitors?

Defibrio ranks 9th amongst 14 active competitors, of which 4 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was HeartHero, which secured $4M in Jun, 2025.

Who are the top competitors of Defibrio?

Defibrio's top competitors include Avive, HeartHero and Nanoomtech. Among them, HeartHero secured the most recent funding round in June, 2025.

Defibrio - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Manufacturer of smartphone connected automated external defibrillator medical hardware devices. This hardware utilizes a mobile device interface to provide cardiac rhythm analysis and deliver lifesaving electrical shocks. The system integrates with smartphone components such as batteries, processors, and screens to reduce device size and maintenance requirements. An associated application provides audio and visual instructions to assist individuals during emergency situations. The system monitors electrode pad expiration and provides automated software updates to maintain device functionality. Hardware connects through a universal serial port to initiate life support procedures when the software identifies cardiac arrest.

Website: defibrio.com
Email ID: *****@defibrio.com

Key Metrics

Founded Year

2020

Location

Bergen, Norway

Stage

Seed

Total Funding

$2.29M in 1 round

Latest Funding Round

Seed, Mar 20, 2022, $*****

Investors

ProVenture

Ranked

9^th among 14 active competitors

Annual Revenue

$0 - $1M as on Dec 31, 2022

Employee Count

1 as on Dec 31, 2022

Similar Companies

Avive & 15 more

View Defibrio's full profile

Defibrio is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
DEFIBRIO AS CIN: 925244538 , Norway, Active		$0 - $1M (As on Dec 31, 2022)	1 (As on Dec 31, 2021)

Defibrio has raised a total funding of $2.29M over 1 round. Its latest funding round was a Seed round on Mar 20, 2022 for $*****. 1 investor participated in its latest round. Defibrio has 1 institutional investor.

Here is the list of recent funding rounds of Defibrio:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 20, 2022	5168360	Seed	7357752	4055983	2885565	4165649

Access funding benchmarks and valuations. Sign up today!

View details of Defibrio's funding rounds and investors

Defibrio's employee count trend

Defibrio has 1 employees as of Dec 22. The total employee count is the same as what it was in Dec 21. Here is Defibrio's employee count trend over the years:

Uncover Defibrio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Defibrio include Avive, HeartHero and Nanoomtech. Here is the list of Top 10 competitors of Defibrio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Avive 2017, Brisbane (United States), Series B	Developer of an automated external defibrillator	$111M	Questa Capital, Laerdal Million Lives Fund ... & 12 others	56/100
2nd	HeartHero 2016, Denver (United States), Series D	Developing next-generation AEDs to improve survival rates from cardiac arrest	$13.6M	Copic, Colorado Office of Economic Development and International Trade ... & 1 others	53/100
3rd	Nanoomtech 2005, Gwangju (South Korea), Series A	Manufactures automatic defibrillator emergency rescue and medical equipment	-	NHN Investment, Prodigy Investment & 1 others	32/100
4th	Complient Corp 1997, Cleveland (United States), Deadpooled	Provides AEDs and CPR equipment and training	$52.2M	Goldman Sachs, Medtronic & 6 others	31/100
5th	Rapid Response Revival Research 2015, Riverwood (Australia), Unfunded	Developer of defibrillator device for cardiac arrest	-	-	28/100
6th	HeartSine 1997, Newtown (United Kingdom), Acquired	Design and manufactore of Automated External Defibrillators(AEDs)	-	Act Venture Capital, Clarendon Fund Managers ... & 1 others	28/100
7th	Butterfly BVM 2016, Indianapolis (United States), Funding Raised	Manufacturer of improved bag-valve-mask devices for CPR	-	HHS	23/100
8th	Cardiac Science 1991, Waukesha (United States), Acqui-Hired	Portfolio of Automated external defibrillators	-	Domain Associates, AlpInvest Partners & 2 others	21/100
9th	Defibrio 2020, Bergen (Norway), Seed	Manufacturer of smartphone connected automated external defibrillator medical hardware devices	$2.29M	ProVenture	20/100
10th	Avenns Medical 2016, Innsbruck (Austria), Unfunded	Developer of a shockwave device for heart muscle regeneration	-	-	19/100